APO-go 50 mg/10 ml, Infusionslösung in einer Fertigspritze

7680631760011 CH-63176 Infusionslösung
APO-go 50 mg/10 ml, Infusionslösung in einer Fertigspritze
APO-go 50 mg/10 ml, Infusionslösung in einer Fertigspritze
APO-go 50 mg/10 ml, Infusionslösung in einer Fertigspritze
1 / 3
google

Article details

Package size
5
Selling units
5
Measure
Fertigspritze(n)
Galenic form
Infusionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
11/10/2023
Summary of Product Characteristics
Français
11/10/2023
Summary of Product Characteristics
Italien
11/10/2023
Patient information leaflet
Allemand
15/04/2021
Patient information leaflet
Français
15/04/2021
Patient information leaflet
Italien
15/04/2021

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
5.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
1.2 MG Substance HBESI

Reimbursement information

Public price
CHF 110.90
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/02/2020

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
63176
Drug name
APO-go 50 mg/10 ml, Infusionslösung in einer Fertigspritze
Galenic form
LSINF
ATC Code
N04BC07
Authorization status
Z
Dispensing category
B
First authorization
07/10/2015
Authorization expiration date
31/12/9999
IT Number
01.08.0.
Domain
Human medicine
Field of application
Morbus Parkinson

Package details

Description (FR)
APO-GO sol perf 50 mg/10ml ser pré 5 x 10 ml
Description (DE)
APO-GO Inf Lös 50 mg/10ml Fertspr 5 x 10 ml
Market launch
07/10/2015
Narcotic (BTM)
No

Other package sizes (1)

APO-GO sol perf 50 mg/10ml ser pré 10 x 10 ml
10 (2 x 5) FESP
GTIN: 7680631760028
View